Medicago Inc MDCGF

RE:nouvlles

[brianpeart]

Company press release Apr.17: ' They are made to look like a virus, allowing them to be recognized readily by the body's immune system, however, they lack the core genetic material making them non-infectious and unable to replicate. Medicago's technology only requires the genetic sequence of a viral strain and not the live influenza virus. This key difference allows vaccines to be manufactured within four weeks of obtaining the genetic sequence of a pandemic strain. This is in contrast with current manufacturing technologies which rely on strain adaptation and can only deliver a vaccine six months after a pandemic is declared. '

The length of time for the MDG system is different than the approval of a routinely used vaccine system with millions of doses given.  The MDG proposal is for a new system only 300 vaccinations. You can see MDG trying various combinations that can be used.  Because of the inexperience with the system for preparing the vaccine, they will have to prove safety and efficay of any vaccine proposal they want approved by a country's regulatory group.  Once a combination has been approved it will be easier to get approval for subsequent vaccines that are the same.

Did you notice that the same press release also talked about the US buying and storing vaccine probably both for poultry and humans.  The US already does that as do other countries including Canada